Humacyte, Inc.
HUMA$0.4011−6.37% 1D
$0.33752-week range$1.90
Updated . Prices are snapshots and may be delayed.
Humacyte, Inc. price chart
+8.38% over 7D
$0.458
$0.352
Oct 18
Oct 20
AI Outlook for Humacyte, Inc.
Bearish posture- Long-term trend-52.1% vs 200-day average
- Medium-term trend-28.8% vs 50-day average
- Averages50-day below 200-day
- 3 more trend and momentum checks
- Nearby support and resistance levels
- What would strengthen or weaken the picture
Posture describes where the price stands today, from its own trend and momentum. It is not a forecast, a price target or financial advice. How it is worked out
Humacyte, Inc. performance
1D
−6.4%
7D
+3.5%
30D
−31.1%
90D
−39.8%
1Y
−76.4%
About Humacyte, Inc.
Humacyte, Inc. is a biotechnology company based in the United States, listed on NASDAQ since 2020 (ticker HUMA).
Humacyte, Inc. market data
What is the price of Humacyte, Inc. today?
Humacyte, Inc. (HUMA) is at $0.4011, −6.37% on the day.
What is the 52-week range of Humacyte, Inc.?
Over the past year Humacyte, Inc. has traded between $0.337 and $1.90. It is currently 4% of the way up that range.
Similar stocks
MRNA
Moderna Inc
$226.89+4.4%
IBRX
Immunitybio Inc
$8.42−8.4%
RXRX
Recursion Pharmaceuticals, Inc. Class A Common Stock
$3.61+2.3%
TCRT
Alaunos Therapeutics, Inc. Common Stock
$3.13+5.0%
BCRX
BioCryst Pharmaceuticals, Inc.
$8.07+3.9%
IOVA
Iovance Biotherapeutics, Inc.
$14.21+3.0%
PDSB
PDS Biotechnology Corporation
$0.9165−18.9%
AKBA
Akebia Therapeutics, Inc.
$0.6801+0.9%
Prices are snapshots from market data providers and may be delayed. This page is for information only and is not investment advice.